Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

P3 Health Partners (PIII) Cost of Revenue (2020 - 2025)

P3 Health Partners (PIII) has disclosed Cost of Revenue for 6 consecutive years, with -$350.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cost of Revenue fell 187.32% year-over-year to -$350.9 million, compared with a TTM value of $1.0 million through Sep 2025, down 99.85%, and an annual FY2024 reading of $1.3 million, down 99.89% over the prior year.
  • Cost of Revenue was -$350.9 million for Q3 2025 at P3 Health Partners, down from $351.3 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $787.8 million in Q4 2022 and bottomed at -$350.9 million in Q3 2025.
  • Average Cost of Revenue over 5 years is $137.3 million, with a median of $1.1 million recorded in 2022.
  • Peak annual rise in Cost of Revenue hit 84767.15% in 2025, while the deepest fall reached 187.32% in 2025.
  • Year by year, Cost of Revenue stood at $295.0 million in 2021, then surged by 167.08% to $787.8 million in 2022, then plummeted by 64.56% to $279.2 million in 2023, then tumbled by 99.83% to $461000.0 in 2024, then crashed by 76227.55% to -$350.9 million in 2025.
  • Business Quant data shows Cost of Revenue for PIII at -$350.9 million in Q3 2025, $351.3 million in Q2 2025, and $181000.0 in Q1 2025.